Evolve BioSystems Inc. Completes $9 million Series A Investment
March 29, 2018 - Less than a minute readEvolve BioSystems Inc. Completes $9 million Series A Investment
Davis, California– Evolve BioSystems, Inc., a microbiotics company developing novel solutions to resolve the dysbiosis in the human infant microbiome that can result from pre-term birth, Caesarian-Section deliveries, and exclusive use of infant formulae, is pleased to announce that it has completed a $9 million Series A Investment to fund the pre-commercialization phase of the Company’s growth.
0 Comments